Hutchinson-gilford progeria syndrome

Chromosomal Instability and Aging: Basic Science and Clinical Implications

Volumn , Issue , 2003, Pages 245-262

  Brown, W Ted ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 10044219566     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (71)

1. F Debusk. The Hutchinson-Gilford progeria syndrome. J Pediatr 80:697-724, 1972.
2. WT Brown, M Zebrower, F Kieras. Progeria, a Model Disease for the Study of Accelerated Aging. In: A Woodhead, AD Blackett, A Hollaender, eds. Molecular Biology of Aging. New York: Plenum Press, 1985, pp 375-396.
3. WT Brown. Progeria: a human-disease model of accelerated aging. Am J Clin Nutr 55:12228-12248, 1992.
4. WT Brown. Human mutations affecting aging: A review. Mech Age Dev 9:325-326, 1979.
5. WJ Hamilton. The biology of the smokey shrew (Sorex fumeus fumeus Miller). Zoologica (NY) 23:473-491, 1940.
6. A Russell. Authenticated national longevity records. In: Guinness 2001 Book of World Records, New York: Sterling, 2001, p. 15.
7. GM Martin. Genetic syndromes in man with potential relevance to the pathobiology of aging. Birth Defects Orig Art Ser 14:5-39, 1977.
8. R Cutler. Evolution of human longevity. Adv Pathobiol 7:43-49, 1980.
9. G Sacher. Mammalian life histories: their evolution and molecular-genetic mechanism. Adv Pathobiol 7:21-42, 1980.
10. M Tokunaga, E Wakamatsu, K Soto, S Satake, K Aoyama, K Saito, M Sugawara, Z Yosizawa. Hyaluronuria in a case of progeria (Hutchinson-Gilford syndrome). J Am Geriatr Soc 26:296-302, 1978.
11. M Goto, K Murata. Urinary excretion of macromolecular acidic glycosaminoglycans in Werner’s syndrome. Clin Chim Acta 85:101-106, 1978.
12. WT Brown, FJ Kieras, GE Houck, R Dutkowski, EC Jenkins. A comparison of adult and childhood progerias: Werner syndrome and Hutchinson-Gilford progeria syndrome. In: D Salk, Y Fujiwara, GM Martin, eds. Werner’s Syndrome and Human Aging. New York: Plenum Press, 1985, pp. 229-244.
13. FJ Kieras, WT Brown, GE Houck, M Zebrower. Elevation of urinary hyaluronic acid in Werner syndrome and progeria. Biochem Med Metab Biol 36:276-282, 1985.
14. M Zebrower, FJ Kieras, WT Brown. Urinary hyaluronic acid elevation in Hutchinson-Gilford progeria syndrome. Mech Age Dev 35:39-46, 1986.
15. T Tajima, T Watanabe, K Iijima, Y Ophshika, H Yamaguchi. The increase of glycosaminoglycans synthesis and accumulation on the cell surface of cultured skin fibroblasts in Werner’s syndrome. Exp Pathol 20:221-229, 1981.
16. R Feinberg, D Beebe. Hyaluronate in vasculogenesis. Science 220:1177-1179, 1983.
17. P Rooney, P Kumar, S Ponting, S Kumar. The role of proteoglycans in tumour an-giogenesis. In: R Bicknell, CE Lewis, N Ferrera, eds. Tumour angiogenesis. Oxford, UK: Oxford Univesity Press, 1997, pp 141-161.
18. C Moen. Orthopaedic aspects of progeria. J Bone Joint Surg 64A:542-546, 1982.
19. JG Gamble. Hip disease in Hutchinson-Gilford progeria syndrome. J Pediatr Orthop 4:585-589, 1984.
20. PB Baker, N Baba, CP Boesel. Cardiovascular abnormalities in progeria. Arch Pathol Lab Med 105:384-386, 1981.
21. CR King, J Lemmer, JR Campbell, AR Atkins. Osteosarcoma in a patient with Hutchinson-Gilford progeria. J Med Genet 15:481-482, 1978.
22. DB Villee, ML Powers. Progeria: a model for the study of aging. In: K Nandy, ed. Senile Dementia: A Biomedical Approach. New York: Elsevier, 1978, pp 259-270.
23. AL Rosenbloom, MS Kappy, FL Debusk, GL Francis, TJ Philpot, MK Maclaren. Progeria: Insulin resistance and hyperglycemia. J Pediatr 102:400-403, 1983.
24. C Epstein, G Martin, A Schultz, A Motulsky. Werner’s syndrome: A review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine 45:177-221, 1966.
25. K Jones, P Smith, M, Harvey, B Hall, L Quan. Older paternal age and fresh gene mutation: data on additional disorders. J Pediatr 86:84-88, 1975.
26. VM Riccardi. Neurofibromatosis. In: Principles and Practice of Medical Genetics. A Emery, D Rimoin, eds. New York: Churchill Livingstone, 1983, p 314.
27. J Viegus, PLR Souza, FM Salzanio. Progeria in twins. J Med Genet 11:384-376, 1974.
28. AH Mostafa, M Gabr. Hereditary progeria with follow-up of two affected sisters. Arch Pediatr 71:163-172, 1954.
29. M Gabr, N Hashem, M Hashem, A Fahni, M Satouh. Progeria, a pathologic study. J Pediatr 57:70-77, 1960.
30. T Rautenstrauch, F Snigula, T Kreig, Gay G, P Muller. Progeria: a cell culture study and clinical report of familial incidence. Eur J Pediatr 124:101-111, 1977.
31. PP Franklin. Progeria in siblings. Clin Radiol 27: 327-333, 1976.
32. H Parkash, SS Sidhu, R Raghavan, RN Desmukh. Huchinson-Gilford progeria: familial occurrence. Am J Med Genet 36: 431-433, 1990.
33. MM Khalifa. Hutchinson-Gilford progeria syndrome: report of a Libyan family and evidence of autosomal recessive inheritance. Clin Genet 35: 125-132, 1989.
34. WT Brown, G Darlington. Thermolabile enzymes in progeria and Werner syndrome: evidence contrary to the protein error hypothesis. Am J Hum Genet 32:614-619, 1980.
35. JE Abdenur, WT Brown, S Friedman, M Smith, F Lifshitz. Response to nutritional and growth hormone treatment in progeria. Metab Clin Exp 46:851, 1997.
36. S Goldstein. Lifespan of cultured cells in progeria. Lancet 7591:424, 1969.
37. GM Martin, CA Sprague, CJ Epstein. Replicative life-span of cultivated human cells: effects of donor’s age, tissue, and genotype. Lab Invest 23:86-92, 1970.
38. S Goldstein, E Moerman. Heat-labile enzymes in skin fibroblasts from subjects with progeria. N Engl J Med 292:1305-1309, 1975.
39. LE Orgel. The maintenance of the accuracy of protein synthesis and its relevance to aging. Proc Natl Acad Sci USA 49:517-521, 1963.
40. S Goldstein, E Moerman. Defective protein in normal and abnormal fibroblasts during aging in vitro. Interdiscip Top Gerontol 10:24-43, 1976.
41. S Goldstein, EJ Moerman. Heat-labile enzymes in circulating erythrocytes of a progeria family. Am J Hum Genet 30:167-173, 1978.
42. WT Brown, GJ Darlington. Thermolabile enzymes in Progeria and Werner syndrome: evidence contrary to the protein error hypothesis. Am J Hum Genet 32: 614-619, 1980.
43. R Wojtyk, S Goldstein. Fidelity of protein synthesis does not decline during aging of cultured human fibroblasts. J Cell Physiol 103:299-303, 1980.
44. RL Walford. Antibody diversity, histocompatibility systems, disease states, and aging. Lancet 7685:1226-1229, 1970.
45. DP Singal, S Goldstein. Absence of detectable HL-A antigens on cultured fibroblasts in progeria. J Clin Invest 52:2259-2263, 1973.
46. WT Brown, GJ Darlington, M Fotino, A Arnold. Detection of HLA antigens in progeria syndrome fibroblasts. Clin Genet 17: 213-219, 1980.
47. T Iwata, GS Incefy, S Cunningham-Rundles, E Smithwick, N Geller, R O’Reilly, RA Good. Circulating thymic hormone activity in patients with primary and secondary immunodeficiency diseases. Am J Med 71:385-394, 1981.
48. J Epstein, JR Williams, JB Little. Deficient DNA repair in human progeroid cells. Proc Natl Acad Sci USA 70:977-981, 1973.
49. J Epstein, JR Williams, JB Little. Rate of DNA repair in progeria and normal fibroblasts. Biochem Biophys Res Commun 59:850-857, 1974.
50. JD Regan, RB Setlow. DNA repair in human progeroid cells. Biochem Biophys Res Commun 59:858-864, 1974.
51. WT Brown, J Epstein, JB Little. Progeria cells are stimulated to repair DNA by cocultivation with normal cells. Exp Cell Res 97:291-296, 1976.
52. WT Brown, JB Little, J Epstein, JR Williams. DNA repair defect in progeria cells. In: D Bergsma, DE Harrison, eds. Genetic Effects on Aging. New York: Liss, pp 417-430, 1977.
53. RR Weichselbaum, J Nove, JB Little. X-ray sensitivity of fifty-three human fibroblast cell strains from patients with characterized genetic disorders. Can Res 40: 920-925, 1980.
54. A Rainbow, M Howes. Decreased repair of gamma ray damaged DNA in progeria. Biochem Biophys Res Commun 74: 714-719, 1977.
55. WT Brown, J Ford, E Gershey. Variation of DNA repair capacity in progeria cells unrelated to growth conditions. Biochem Biophys Res Commun 97:347-353, 1980.
56. S Wang, C Nishigori, T Yage, H Takebe. Reduced DNA repair in progeria cells and effects of gamma-ray irradiation on UV-induced unscheduled DNA synthesis in normal and progeria cells. Mutat Res 256: 59-66, 1991.
57. J Oshima, WT Brown, GM Martin. No detectable mutations at Werner helicase locus in progeria. Lancet 348: 1106, 1996.
58. S Goldstein, S Niewiarowski. Increased procoagulant activity in cultured fibroblasts from progeria and Werner’s syndrome of premature aging. Nature 260:711-713, 1976.
59. JR Magniord, BE Dreyer, MB Stemerman, FA Pitlick. Tissue factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts. Blood 50:387-396, 1977.
60. AL Rosenbloom, S Goldstein. Insulin binding to cultured human fibroblasts increases with normal and precocious aging. Science 19:412-415, 1976.
61. GC Sephel, A Sturrock, MG Giro, JM Davidson. Increased elastin production by progeria skin fibroblasts is controlled by the steady-state levels of elastin mRNA. J Invest Dermatol 90:643-647, 1988.
62. MA Clark, AS Weiss. Elevated levels of glycoprotein gp200 in progeria fibroblasts. Mol Cell Biochem 120:51-60, 1993.
63. DH Ly, DJ Lockhart, RA Learner, PG Schultz. Mitotic misregulation and human aging. Science 287:2486-2492, 2000.
64. WY Park, CI Hwang, MJ Kang, JY Seo, JH Chung, YS Kim, JH Lee, KA Kim, HJ Yoo, JS Seo. Gene profile of replicative senescence is different from progeria or elderly donor. Biochem Biophys Res Commun 282:934-939, 2001.
65. K Murata. Urinary acidic glycosaminoglycans in Werner’s syndrome. Experientia 38:313-314, 1982.
66. M Zebrower, FJ Kieras, WT Brown. Analysis by high-performance liquid chromatography of hyaluronic acid and chondroitin sulfates. Anal Biochem 157:93-99, 1986.
67. M Solursh, G Moriss. Glycosaminoglycan synthesis in rat embryos during the formulation of the primary mesenchyme and neural folds. Dev Biol 57:75-86, 1977.
68. ED Hay. Development of the vertebrate cornea. Int Rev Cytol 63:263-322, 1980.
69. B Toole. Glycosaminoglycans in morphogenesis. In: E Hay, ed. Cell Biology of Extracellular Matrix. New York: Plenum Press, 1981, pp 259-288.
70. DC West, IN Hampson, F Arnold, S Kumar. Angiogenesis induced by degradation products of hyaluronic acid. Science 228:1324-1326, 1985.
71. M Slevin, J Krupinski, S Kumar, J Gaffney. Angiogenic oligosaccharides of hyaluro-nan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest 78: 987-1003, 1998.